Zeto develops the zEEG, a commercially available wireless EEG headset integrated with a cloud platform that offers instant upload, analysis tools and remote interpretation by neurologists. The zEEG system is approved by the U.S. Food and Drug Administration for clinical use. The company is led by founder and CEO Aswin Gunasekar, MS, MBA. Zeto plans to use new capital to accelerate commercialization of its lead product and to develop additional products to expand its portfolio. The company positions its offering at the intersection of medical hardware and cloud-based clinical workflow software. The fundraising strengthens its financial position to support go-to-market and product development efforts.

Total raised

$7M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2020